Broad-Spectrum Antibiotic Therapy for Nosocomial Pneumonia in ICU
Author Information
Author(s): Álvarez-Lerma Francisco, Alvarez Bernabe, Luque Pilar, Ruiz Francisco, Dominguez-Roldan Jose-Maria, Quintana Elisabet, Sanz-Rodriguez Cesar
Primary Institution: Hospital del Mar, Barcelona, Spain
Hypothesis
De-escalation of antibiotics is feasible but highly dependent on microbiological investigations and clinical characteristics.
Conclusion
De-escalation of antibiotics was less likely in patients with potentially multiresistant pathogens, highlighting barriers to its implementation.
Supporting Evidence
- De-escalation was implemented in only 23% of patients with potentially multiresistant pathogens.
- Response rates were 53% for patients continuously treated with imipenem-based regimens.
- Prior antibiotic administration was associated with lower de-escalation rates.
Takeaway
Doctors give strong antibiotics to sick patients, but sometimes they can switch to weaker ones if they know what germs are causing the illness. This study shows that it's hard to do this when the germs are really tough.
Methodology
A prospective observational study conducted in 24 ICUs in Spain, assessing patients with nosocomial pneumonia treated with imipenem-based regimens.
Potential Biases
Potential bias due to the lack of guidance on antibiotic de-escalation and variability in initial antibiotic choices across institutions.
Limitations
Lack of a control group, no standardized de-escalation recommendations, and a high proportion of patients without microbiological documentation.
Participant Demographics
Patients aged ≥18 years with nosocomial pneumonia, predominantly late-onset cases.
Statistical Information
P-Value
0.001
Confidence Interval
63% to 76%
Statistical Significance
p<0.001
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website